Kbc Group Nv Alkermes Plc. Transaction History

Kbc Group Nv

$36.3 Billion
Q4 2024

A detailed history of Kbc Group Nv transactions in Alkermes Plc. stock. As of the latest transaction made, Kbc Group Nv holds 7,176 shares of ALKS stock, worth $244,199. This represents 0.0% of its overall portfolio holdings.

Number of Shares

7,176

Previous 4,890 46.75%

Holding current value

$244,199

Previous $137,000 50.36%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 22, 2025	BUY	$25.7 - $31.46 $58,750 - $71,917	2,286 Added 46.75%	7,176 $206,000
Q3 2024 Nov 06, 2024	BUY	$23.01 - $28.55 $17,809 - $22,097	774 Added 18.8%	4,890 $137,000
Q2 2024 Jul 17, 2024	BUY	$23.21 - $27.24 $3,690 - $4,331	159 Added 4.02%	4,116 $99,000
Q1 2024 May 08, 2024	BUY	$26.4 - $32.56 $21,120 - $26,048	800 Added 25.34%	3,957 $107,000
Q4 2023 Feb 13, 2024	BUY	$23.37 - $28.68 $73,779 - $90,542	3,157 New	3,157 $88,000
Q2 2021 Aug 11, 2021	SELL	$18.78 - $25.15 $23,587 - $31,588	-1,256 Closed	0 $0
Q1 2021 Apr 26, 2021	BUY	$18.21 - $23.2 $22,871 - $29,139	1,256 New	1,256 $23,000
Q1 2020 May 04, 2020	SELL	$13.06 - $21.24 $77,876 - $126,654	-5,963 Closed	0 $0
Q4 2019 Feb 11, 2020	SELL	$17.29 - $21.74 $185,020 - $232,639	-10,701 Reduced 64.22%	5,963 $122,000
Q3 2019 Nov 07, 2019	SELL	$19.51 - $24.28 $54,198 - $67,449	-2,778 Reduced 14.29%	16,664 $325,000
Q2 2019 Jul 30, 2019	SELL	$21.47 - $37.33 $20,160 - $35,052	-939 Reduced 4.61%	19,442 $0
Q1 2019 May 10, 2019	SELL	$28.4 - $36.49 $1.48 Million - $1.91 Million	-52,220 Reduced 71.93%	20,381 $0
Q4 2018 Jan 31, 2019	SELL	$27.94 - $44.61 $1.23 Million - $1.96 Million	-43,919 Reduced 37.69%	72,601 $2.14 Million
Q3 2018 Nov 14, 2018	SELL	$38.6 - $46.12 $1.41 Million - $1.69 Million	-36,619 Reduced 23.91%	116,520 $0
Q2 2018 Aug 03, 2018	SELL	$40.56 - $51.36 $2.14 Million - $2.71 Million	-52,770 Reduced 25.63%	153,139 $0
Q1 2018 May 09, 2018	SELL	$53.61 - $67.26 $233,846 - $293,388	-4,362 Reduced 2.07%	205,909 $0
Q4 2017 Feb 07, 2018	SELL	$47.69 - $55.39 $2.87 Million - $3.33 Million	-60,144 Reduced 22.24%	210,271 $0
Q3 2017 Nov 13, 2017	BUY	$49.16 - $54.45 $13.3 Million - $14.7 Million	270,415	270,415 $0

Others Institutions Holding ALKS

# of Institutions

376

Shares Held

173M

Call Options Held

231K

Put Options Held

158K

View Full List

About Alkermes plc.

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $5.59B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

More about ALKS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kbc Group Nv, based on Form 13F filings with the SEC.

News

Stay updated on Kbc Group Nv with notifications on news.

Account